Literature DB >> 15513384

Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.

H Bell1, J Jahnsen, E Kittang, N Raknerud, L Sandvik.   

Abstract

BACKGROUND: Most follow-up studies in patients with alcoholic liver cirrhosis have been for a 5-year period or less. The aim of this study was to assess the long-term mortality and causes of death among patients with alcoholic liver cirrhosis and to identify predictors of mortality.
METHODS: One hundred patients with alcoholic liver cirrhosis, consecutively admitted to one medical department, were included in the study from May 1984 until December 1988. All patients had a history of alcohol abuse of at least 100 g ethanol daily for several years. The study comprised 65 men and 35 women with a median age of 58 years (range 34-82). Percutaneous liver biopsies and/or autopsies were obtained on 89 patients. Sixty-seven had ascites at admission and 34% had bleeding oesophageal varices. All patients were followed prospectively until death or until October 2000.
RESULTS: During the follow-up period 90% of the patients died, 68 of whom (76 %) had been autopsied. The cumulative actuarial mortality after 1, 3, 6 and 12 months was 18%, 28%, 36% and 49%, respectively and after 5, 10 and 15 years 71%, 84% and 90%, respectively. None of the patients underwent liver transplantation during the study. The causes of death were bleeding, liver failure or a combination of these two conditions in 52 of 90 patients (58%), while 9 (11%) died of hepatocellular carcinoma 0.5 to 73 months after inclusion in the study. Using the Cox regression analysis, age, alcohol abuse and alkaline phosphatase were independent and significant predictors of mortality, but Child-Pugh class was not.
CONCLUSIONS: The mortality in a group of patients with advanced alcoholic cirrhosis was extremely high with 5 and 15 years' mortality in 71% and 90%, respectively. Independent predictors of a poor prognosis were high age, continuous alcohol consumption of more than 10 g ethanol per day and high levels of alkaline phosphatase.

Entities:  

Mesh:

Year:  2004        PMID: 15513384     DOI: 10.1080/00365520410006350

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  18 in total

Review 1.  Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease.

Authors:  Nobuyuki Toshikuni; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

3.  The costs of hazardous alcohol consumption in Germany.

Authors:  Tobias Effertz; Frank Verheyen; Roland Linder
Journal:  Eur J Health Econ       Date:  2016-08-20

Review 4.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

Review 5.  Molecular prognostic prediction in liver cirrhosis.

Authors:  Nicolas Goossens; Shigeki Nakagawa; Yujin Hoshida
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

6.  Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol.

Authors:  Ashwin D Dhanda; Hannah Allende; Victoria Allgar; Jackie Andrade; Matthew Peter Bailey; Lynne Callaghan; Laura Cocking; Elizabeth Goodwin; Annie Hawton; Christopher Hayward; Ben Hudson; Alison Jeffery; Angela King; Victoria Lavers; Joe Lomax; C Anne McCune; Richard Parker; Christopher Rollinson; Jonny Wilks; E Siobhan Creanor
Journal:  BMJ Open       Date:  2022-05-18       Impact factor: 3.006

7.  Survival of patients with primary liver cancer in central and northern Denmark, 1998-2009.

Authors:  Jonathan Montomoli; Rune Erichsen; Mette Nørgaard; Morten Høyer; Jesper Bach Hansen; Jacob Bonde Jacobsen
Journal:  Clin Epidemiol       Date:  2011-07-21       Impact factor: 4.790

8.  Autologous bone marrow stem cells in the treatment of chronic liver disease.

Authors:  Madhava Pai; Duncan Spalding; Feng Xi; Nagy Habib
Journal:  Int J Hepatol       Date:  2011-11-03

9.  Retrospective study of the clinical profile and prognostic indicators in patients of alcoholic liver disease admitted to a tertiary care teaching hospital in Western Nepal.

Authors:  Om K Pathak; Raju Paudel; Om B Panta; Hom P Pant; Bishnu R Giri; Baikuntha Adhikari
Journal:  Saudi J Gastroenterol       Date:  2009 Jul-Sep       Impact factor: 2.485

10.  Survival of patients with alcoholic and cryptogenic cirrhosis without liver transplantation: a single center retrospective study.

Authors:  Sudul Mananjala Senanayake; Madunil Anuk Niriella; Sanjaya Kumara Weerasinghe; Anuradhani Kasturiratne; Jerome Praneeth de Alwis; Arjuna Priyadarsin de Silva; Anuradha Supun Dassanayake; Hithanadura Janaka de Silva
Journal:  BMC Res Notes       Date:  2012-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.